Does not apply

OTHER5 trials

Sponsors

Pfizer, Jörg Schefold, Asociación Colombiana de Hepatología, Universitair Medisch Centrum Utrecht

Conditions

Acute Kidney InjuryAortic SurgeryBiomarkerCandidemiaDialysisEsophagitisHepatitis C Virus InfectionInvasive Candidiasis

Unknown Phase

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

TerminatedNCT01213823

PfizerCandidemia, Invasive Candidiasis

Start: 2008-09-30End: 2011-05-31Updated: 2016-03-30

Risk of Cancer Among Pantoprazole Users

CompletedNCT01322633

PfizerEsophagitis

Start: 2004-07-31End: 2013-03-31Updated: 2014-02-20

(TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery

CompletedNCT03469765

Jörg SchefoldAcute Kidney Injury, Aortic Surgery, Biomarker +2

Start: 2018-06-19End: 2019-09-23Updated: 2019-09-24

Regulating Rheumatoid Arthritis

RecruitingNL-OMON52768

Universitair Medisch Centrum Utrechtrheumatoid arthritis

Start: 2023-03-23Target: 145Updated: 2025-10-13

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

RecruitingNCT06463912

Asociación Colombiana de HepatologíaHepatitis C Virus Infection

Start: 2024-05-20End: 2025-03-31Target: 205Updated: 2024-06-18

Related Papers

(TIMP2) x (IGFBP7) as early renal biomarker for the prediction of acute kidney injury in aortic surgery (TIGER). A single center observational study

PLoS ONE2021-01-0717 citations